Dr. Jianjun Yu 喻建军
Chief Physician
Department of Head and Neck Surgery, Hunan Cancer Hospital, Changsha
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Repair of large defects after oral and maxillofacial tumor surgery, functional organ reconstruction, larynx-preserving surgeries, and functional reconstruction of the upper and lower jaws.
Dr. Yu holds a medical doctorate and has trained at China Medical University First Hospital, Shanghai Jiao Tong University Ninth People’s Hospital, and hospitals in Paris. With extensive experience in head and neck tumor surgery, Dr. Yu has performed over 300 microsurgical flap reconstructions. Research includes digital virtual surgery-assisted jaw reconstruction and cryotherapy for oral mucosal malignant melanoma.
Professional roles
- Vice Chair, Hunan Province Oral and Maxillofacial Surgery Professional Committee
- Member, Tumor Plastic Surgery Group, Plastic Surgery Association of the Chinese Medical Association
- Vice Chair, Provincial Tumor Rehabilitation Medical Association
- Standing Committee Member, Provincial Stomatological Association
Name order: in Chinese the family name comes first (Yu Jianjun). Papers usually list the name as Jianjun Yu or Yu J.
Selected publications
26 papers on PubMed matched by name and affiliation; 5 as first or senior author since 2016. Most recent first- or senior-author papers:
- JAMA Oncol, 2025 (senior author): Toripalimab Plus Chemotherapy as a First-Line Therapy for Extensive-Stage Small Cell Lung Cancer: The Phase 3 EXTENTORCH Randomized Clinical Trial. PubMed 39541202
- DNA Cell Biol, 2021 (senior author): Bioinformatics Analysis of the Signaling Pathways and Genes of Gossypol Induce Death of Nasopharyngeal Carcinoma Cells. PubMed 34191589
- Int J Med Sci, 2021 (senior author): A review of linc00673 as a novel lncRNA for tumor regulation. PubMed 33390809
- Oncotarget, 2017 (first author): Overexpression long non-coding RNA LINC00673 is associated with poor prognosis and promotes invasion and metastasis in tongue squamous cell carcinoma. PubMed 28039470
- J Cancer, 2017 (first author): Upregulated long non-coding RNA LINC00152 expression is associated with progression and poor prognosis of tongue squamous cell carcinoma. PubMed 28367232
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion